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Abstract
Background: Surgical site infections (SSI) are a major cause of increased morbidity and cost after a
pancreatectomy. Patients undergoing a pancreatectomy frequently have had recent inpatient hospital
admissions prior to their surgical admission (recent pre-surgical admission, RPSA), which could
increase the risk of SSI.
Methods: The 2009–2011 Healthcare Cost Utilization Project California State Inpatient Database was
used. Chi-square tests, Student’s t-tests and multivariable logistic regression were used.
Results: Three thousand three hundred and seventy-six patients underwent a pancreatectomy, and
444 (13.2%) had RPSA. One hundred and eighty (40.5%) RPSAs were to different hospitals other than
where patients’ pancreatectomy took place. In univariate analysis, patients with RPSA had a signifi-
cantly higher rate of post-operative SSIs, and this was associated with a longer length of post-opera-
tive stay, higher post-operative hospital costs and increased postoperative 30-day readmission rates
(Table 1). In Multivariate analysis, RPSA was an independent predictor of post-operative SSI [odds
ratio (OR) = 1.68, P = 0.013], and the risk of SSI increased with increasing RPSA length of stay
(OR = 1.07 per day, P = 0.001).
Conclusions: Recent pre-surgical admission is an important risk factor for SSI after a pancreatec-
tomy. Many patients with RPSA are not admitted pre-operatively to the same hospital where the pan-
createctomy occurs; in such circumstances, SSI rates may not be a sole reflection of the care
provided by operating hospitals.
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Background
Surgical Site Infections (SSI) are a major cause of increased
cost and morbidity after a pancreatectomy.1 SSI after a major
hepatopancreatobiliary (HPB) operation increases hospital
costs by an average of $11 462 per event.2 In addition, SSIs are
considered a hospital-acquired condition and are being used as
a quality metric for patient care. Hospitals currently receive
financial penalties for high rates of SSI after certain types of
surgery, such as coronary artery bypass, and it is likely that
these penalties will be extended to other types of operations in
the coming years. Furthermore, complications such as SSI can
delay adjuvant therapy after oncological surgery, which could
ultimately impact on survival.3
Risk factors for post-operative SSI can be divided into
patient- and procedure-related.4 Many of these risk factors are
targeted by methods such as the Surgical Care Improvement
Program (SCIP) as well as through patient medical optimiza-
tion.5 However, patients undergoing a pancreatectomy fre-
quently have had recent inpatient hospital admissions prior to
their surgical admissions (recent pre-surgical admission,
RPSA), which could also increase the risk of post-operative
SSI. Recently, hospitalized patients are more likely to be colo-
nized by antibiotic resistant, virulent bacteria, such as methicil-
lin-resistant Staphylococcus aureus (MRSA), which can
predispose patients to infections.6 In addition, hospitalized
patients are more likely to receive interventions which can
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predispose to infection, such biliary stenting7,8 and a blood
transfusion.9 The aim of this study was to examine whether
patients who are hospitalized within 30 days prior to surgery
for any reason are at a higher risk of post-operative SSI after a
pancreatectomy.
Patients and methods
Study design and patient population
This study was a retrospective cohort study using the Agency
for Healthcare Research and Quality (AHRQ) Healthcare Cost
and Utilization (HCUP) State Inpatient Database (SID)10 for
California from 2009 to 2011 to identify patients undergoing a
pancreaticoduodenectomy [International Classification of Dis-
eases, Ninth Revision, Clinical Modification (ICD9-CM) proce-
dure codes: 52.51 and 52.7], a total pancreatectomy (ICD9-CM
procedure code: 52.6) and a distal pancreatectomy (ICD9-CM
procedure codes: 52.52). Variables are included in this database
to track sequential visits for a patient within a state and across
facilities and hospital settings. These variables include a per-
son-level identifier (VisitLink) and a timing variable (DaysTo-
Event) which can be used to determine the days between
hospital events for a patient. Using this approach, patients
were identified with admission to any hospital from 1 to
30 days before their surgical admission and from 1 to 30 days
post-surgical discharge. For simplicity, only the last admission
prior to surgery and the first readmission after surgery were
considered. RPSA was defined as inpatient stays > 48h with a
date of discharge within 30 days prior to admission for a pan-
createctomy. Patients under the age of 18 years and patients
with missing VisitLink or DaysToEvent variables were
excluded. Also excluded were patients who underwent hospi-
tal-to-hospital transfer for a pancreatectomy (n = 159) as this
was thought to represent a separate phenomenon from RPSA.
Table 1 Characteristics of pancreatectomy patients with and
without recent pre-surgical admission (RPSA) (n = 3376)
Characteristic No. (Column %) or Mean
(SD)
P-value
No RPSA
(n = 2932,
86.9%)
RPSA
(n = 444,
13.2%)
Age, year 63.5 (12.8) 64.3 (12.2) 0.210
Gender
Male 1429 (48.9%) 240 (54.1%) 0.108
Female 1476 (50.3%) 201 (45.3%)
Missing 27 (0.9%) <11a
Race
White 1751 (59.7%) 234 (52.7%) 0.005
Non-white 1181 (40.3%) 210 (47.3%)
Comorbidities
Congestive
heart failure
89 (3.0%) 17 (3.8%) 0.372
Chronic lung
disease
341 (11.6%) 54 (12.2%) 0.745
Diabetes 669 (22.8%) 124 (27.9%) 0.179
Chronic renal
failure
154 (5.3%) 30 (6.8%) 0.193
Chronic
pancreatitis
285 (9.7%) 60 (13.5%) 0.014
Obesity 274 (9.4%) 34 (7.7%) 0.250
Weight loss 325 (11.1%) 83 (18.7%) <0.001
Liver disease 167 (5.7%) 20 (4.5%) 0.307
Alcohol abuse 108 (3.7%) 16 (3.6%) 0.934
Median state income quartileb
1st quartile 484 (16.5%) 122 (27.5%) <0.001
2nd quartile 632 (21.6%) 96 (21.6%)
3rd quartile 824 (28.1%) 109 (24.6%)
4th quartile 935 (31.9%) 107 (24.1%)
Missing 57 (1.9%) <11a
Pancreatectomy type
Whipple 1944 (66.3%) 380 (85.6%) <0.001
Total 102 (3.5%) 18 (4.1%)
Distal 886 (30.2%) 46 (10.4%)
Diagnosis
Malignant 1972 (67.3%) 360 (81.1%) <0.001
Benign 960 (32.7%) 84 (18.9%)
Biliary obstruction 506 (17.3%) 136 (30.6%) <0.001
Surgical admission
preoperative
length of
stay, day
1.4 (4.4) 1.7 (4.7) 0.132
Table 1 Continued
Characteristic No. (Column %) or Mean
(SD)
P-value
No RPSA
(n = 2932,
86.9%)
RPSA
(n = 444,
13.2%)
Hospital pancreatectomy volume quartile
1st quartile
(<26 patients)
738 (25.2%) 133 (30.0%) 0.0724
2nd& 3rd quartile
(26–149 patients)
1504 (51.3%) 206 (46.4%)
4th quartile
(>149 patients)
690 (23.5%) 105 (23.7%)
a
Cells with fewer than 11 patients per variable are relabelled as ‘<11’ in
compliance with the HCUP data use agreement.
b
Median State Income Quartiles are calculated by HCUP using the
patient’s zip code and the state of California’s income data.
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Study variables
Common post-operative complications and procedures using
ICD9-CM diagnosis and procedure codes were used based on
previous work in pancreatectomy patients.11 The AHRQ com-
orbidity software, version 3.7 (AHRQ, Rockville, MD, USA)
was used to identify comorbidities present at initial surgical
admission by utilizing measures defined by Elixhauser et al.12
based on ICD9-CM diagnosis codes. Hospital volume quartiles
were identified using the total number of pancreatectomies per-
formed at individual hospitals between 2009 and 2011. The
median state income quartiles are calculated by HCUP using
the patient’s zip code and the state of California’s income data,
and patients are categorized accordingly. Total hospital charges
were converted to costs using the HCUP hospital-specific cost-
to-charge ratio file. Cells with fewer than 11 patients per vari-
able were relabelled as ‘< 11’ in compliance with the HCUP
data use agreement.
Statistical analysis
Chi-square and Student’s t-tests were used for univariate com-
parisons. Multivariable logistic regression was used to examine
the association of RPSA and SSI. Models included age, gender,
race, state income quartile, comorbidities (congestive heart fail-
ure, chronic lung disease, cancer status, hospital pancreatectomy
volume quartile, pre-operative endoscopic pancreatic or biliary
decompression, biliary obstruction at surgery, surgical admis-
sion pre-operative length of stay and RPSA (or RPSA length of
stay)]. All P-values were two-sided and values <0.05 were con-
sidered statistically significant in all analyses. All statistics were
performed using SAS version 9.3 (SAS Inc. Cary, NC, USA).
Results
In total, from 2009 to 2011, 3376 patients underwent a pancrea-
tectomy , and were included in the study (Table 1). The average
age was 64 years, roughly half were female, and about two-thirds
of pancreatectomies were performed for cancer. Approximately
13% of patients had RPSA. Patients with RPSA were more likely
to be of a non-white race and a lower income status. In addition,
patients with RPSA were more likely to have chronic pancreatitis
as well as weight loss. RPSA patients were more likely to undergo
a pancreaticoduodenectomy and less likely to undergo a distal
pancreatectomy. Cancer and biliary obstruction were also more
common among patients with RPSA.
The details surrounding RPSA hospital stays were examined
(Table 2). The two most common non-cancer diagnoses at
RPSA were biliary obstruction and pancreatitis. Approximately
41% of patients underwent pancreatic or biliary decompression
during RPSA. The median length of RPSA stay was 5 days,
and the average interval between RPSA discharge until surgical
admission was 17 days. Roughly 40% of RPSA were to hospi-
tals other than where patients’ pancreatectomy took place (out-
side hospitals, OSH).
In univariate analysis, patients with RPSA had higher rates
of both superficial/deep incisional SSI as well as organ space
SSI (Table 3). In addition, patients with RPSA had longer
median hospital stays, higher median hospital costs and a
higher rate of 30-day readmission. In multivariate analysis,
weight loss, having a pancreaticoduodenectomy or total pan-
createctomy (with distal pancreatectomy as the reference
group), surgical admission length of stay and RPSA were all
independently associated with an increased risk of post-opera-
tive SSI (Table 4). Furthermore, the risk of SSI increased with
increasing RPSA length of stay (Table 5).
Discussion
In the present study, RPSA was associated with an increased
risk of SSI after a pancreatectomy. Additionally, many patients
with RPSA are admitted to OSH, which may have
Table 2 Details of recent pre-surgical admissions within 30-days
of a pancreatectomy
Variable No (%) or
median (range)
Pancreatitis 164 (36.9%)
Biliary obstruction 255 (57.4%)
Pancreatic or biliary decompression 183 (41.2%)
Length of stay, day 5 (3–39)
Interval post discharge until surgery, day 17 (1–30)
Admission to outside hospital 180 (40.5%)
Table 3 Post-operative outcomes of patients with and without
recent hospital admissions prior to a pancreatectomy (n = 3376)
Variable No recent
admission
(n = 2932)
Recent
admission
(n = 444)
P-value
Superficial/Deep
incisional
surgical site
infection (%)
288 (9.8%) 64 (14.4%) 0.003
Organ space
surgical site
infection (%)
163 (5.6%) 36 (8.1%) 0.034
Any surgical site
infection (%)
339 (11.6%) 77 (17.4%) <0.001
Post-operative
length of hospital
stay, median
days (SD)
9 (10.8) 11 (11.5) <0.001
Post-operative
hospital costs,
median $ (SD)
40 927 (44 342) 53 909 (54 986) <0.001
Post-operative
30-day
readmission (%)
591 (20.8%) 115 (27.1%) 0.003
Surgical site infections defined by ICD-9-CM codes11
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consequences for operating hospitals beyond their control. The
impact of hospital exposure on infection rates is well docu-
mented; 13 however, little is known about the impact that
recent hospitalization has on the future risk of post-operative
infection at a later admission. RPSA is associated with an
increased risk of SSI after a pancreatectomy, but it is unknown
how long after discharge patients remain at an increased risk.
Future work should examine whether delaying the interval
between RPSA discharge and surgery affects this risk. Cur-
rently, efforts are being focused on reducing time in the hospi-
tal after surgery by promoting decreased post-operative length
of stay and reduced readmission rates. However, the current
study raises the possibility that perhaps reducing hospitaliza-
tion or implementing interventions to reduce the risk of SSI as
well as other complications even before the surgical admission
should also be a priority. It has recently been proposed that
the ability of patients to receive post-operative oncological
therapy (return to intended oncological treatment, RIOT)
should be used as a quality indicator of surgical care.14 As
complications such as SSI directly affect RIOT, reducing RPSA
could potentially improve the rate of RIOT after a pancreatec-
tomy.
Hospitalization adversely impacts post-operative outcomes
after a pancreatectomy. Pratt et al.15 demonstrated that patients
who were hospitalized pre-operatively and underwent a pancre-
atectomy during the same admission had worse postoperative
outcomes. The present study differed in that it examined the
impact of remote hospitalization on SSI after a pancreatectomy.
This is an important distinction for a few reasons. First of all,
the present study suggests that the adverse effects of hospitaliza-
tion may in fact persist beyond the immediate period of hospi-
talization. Thus, a recently discharged patient who is later
admitted for a pancreatectomy still appears to be at increased
risk of an adverse outcome. In addition, the length of stay prior
to surgery during patients’ surgical admissions is easily
accounted for in risk-adjustment given that they are receiving
care in the same hospital in which their surgery occurs. How-
ever, RPSA is not accounted for by current methods of post-
operative risk prediction, such as the NSQIP risk calculator.14
Accounting for RPSA in risk-adjustment is especially difficult
given that many patients are not admitted to the same hospital
where their pancreatectomy takes place – 40% in the present
study. RPSA to outside hospitals may adversely affect outcomes
of the operating hospital, and erroneously impact the perceived
quality of care at tertiary referral hospitals.
Previous studies have identified pre-operative malnutrition
and weight loss as independent predictors of SSI after a pan-
createctomy.16,17 The current study confirmed this finding at
the population level. The finding that a pancreaticoduodenec-
tomy and a total pancreatectomy are associated with increased
SSI (using distal pancreatectomy as the reference group) is not
surprising. Distal pancreatectomies are increasingly being done
laparoscopically, which can reduce superficial SSI rates.18 In
addition, the enteric and biliary anastomoses involved with a
pancreaticoduodenectomy and a total pancreatectomy likely
also increase the incidence of post-operative SSI. Surgical
admission pre-operative length of stay was also an indepen-
dently associated with post-operative SSI in the present study.
This finding along with the association of RPSA length of stay
with increased SSI risk supports the overarching conclusion of
this work – that recent pre-operative hospital exposure
increases the risk of SSI.
Others have shown that pre-operative biliary decompression
is associated with an increased risk of SSI.7,8 The present study
did not find this association. One reason for this could be that
the database was limited to inpatient admissions to acute care
hospitals, and, therefore, could not identify patients undergo-
ing stenting procedures on an outpatient basis. It is becoming
increasingly common for patients presenting electively with
obstructive jaundice and a peri-ampullary mass to undergo an
outpatient endoscopic ultrasound with biopsy; at which time,
Table 5 Significant factors associated with post-operative surgical
site infection after a pancreatectomy in multivariable logistic
regression with recent pre-surgical admission (RPSA) length of
stay as a continuous variable
Characteristic OR 95% CI P-value
Comorbidities
Weight loss 1.45 1.10 1.93 0.010
Pancreatectomy type
Whipple 3.57 2.52 5.06 <0.001
Total 2.64 1.39 5.01 0.003
Distal [reference]
Surgical admission
preoperative length
of stay, per day
1.05 1.03 1.07 <0.001
RPSA length of stay, per day 1.07 1.03 1.12 0.001
Table 4 Significant factors associated with post-operative surgical
site infection after a pancreatectomy in multivariable logistic
regression with recent pre-surgical admission (RPSA) as a
categorical variable
Characteristic OR 95% CI P-value
Comorbidities
Weight Loss 1.47 1.11 1.95 0.008
Pancreatectomy type
Whipple 3.54 2.50 5.01 <0.001
Total 2.69 1.42 5.10 0.002
Distal [reference]
Surgical admission
preoperative length
of stay, per day
1.05 1.03 1.07 <0.001
RPSA 1.68 1.12 2.52 0.013
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many gastroenterologists simultaneously perform an endo-
scopic retrograde cholangiopancreatogram with stenting. Addi-
tionally, perhaps some stenting procedures were performed
outside the pre-operative 30-day timeframe, and, therefore,
were not detected in the present study.
The present study has some limitations. The HCUP SID is
an administrative database and relies on ICD-9CM codes; thus,
there is the potential for coding error or bias. This study uti-
lized population level data and, therefore, could not examine
many of the details surrounding admissions and surgery.
Owing to the nature of the database, only inpatient data were
able to be examined and any SSI diagnosed in the outpatient
setting could not be detected. Unfortunately, microbiological
data are not available in the database used in the present study.
It would be interesting to see if the organisms responsible for
the SSI were the same as those cultured in the bile or if they
were more likely to be ‘hospital-acquired’ organisms, such as
MRSA. Finally, as with any retrospective study, residual con-
founding owing to variables not included in the database could
also bias the results.
In conclusion, RPSA is an important risk factor for SSI after
a pancreatectomy and the risk of SSI increases with increasing
RPSA length of hospital stay. Furthermore, many patients with
RPSA are not admitted to the same hospital where the pancre-
atectomy occurs; in such circumstances, SSI rates may not be a
sole reflection of the care provided by operating hospitals.
Future attempts to predict, risk-adjust for, and prevent SSI
should take into account RPSA as an indicator of increased
SSI risk, both in a pancreatectomy and perhaps in other surgi-
cal procedures.
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